4D2S
Human TTK in complex with a Dyrk1B inhibitor
Summary for 4D2S
Entry DOI | 10.2210/pdb4d2s/pdb |
Related | 4D2R |
Descriptor | DUAL SPECIFICITY PROTEIN KINASE TTK, N-{2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]phenyl}-4-(1H-pyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine (3 entities in total) |
Functional Keywords | transferase, oncology |
Biological source | HOMO SAPIENS (HUMAN) |
Total number of polymer chains | 1 |
Total formula weight | 33089.01 |
Authors | Debreczeni, J.E.,Kettle, J.G.,Ballard, P.,Bardelle, C.,Butterworth, S.,Colclough, N.,Critchlow, S.E.,Fairley, G.,Fillery, S.,Graham, M.A.,Goodwin, L.,Guichard, S.,Hudson, K.,Mahmood, A.,Vincent, J.,Ward, R.A.,Whittaker, D. (deposition date: 2014-05-12, release date: 2015-04-22, Last modification date: 2024-05-08) |
Primary citation | Kettle, J.G.,Ballard, P.,Bardelle, C.,Cockerill, M.,Colclough, N.,Critchlow, S.E.,Debreczeni, J.E.,Fairley, G.,Fillery, S.,Graham, M.A.,Goodwin, L.,Guichard, S.,Hudson, K.,Ward, R.A.,Whittaker, D. Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors to Explore a Mek Resistance Hypothesis. J.Med.Chem., 58:2834-, 2015 Cited by PubMed Abstract: Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response. PubMed: 25738750DOI: 10.1021/ACS.JMEDCHEM.5B00098 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.5 Å) |
Structure validation
Download full validation report